Agenus (AGEN) Change in Intangibles (2026)
Agenus (AGEN) posted quarterly Change in Intangibles of $63.9 million for Q1 2026.
Powered by 
Analysis
Agenus (AGEN) Change in Intangibles (2026) Analysis & Trends
Agenus' Change in Intangibles history runs 1 years deep, the most recent figure standing at $63.9 million for Q1 2026.
- In Q1 2026, Change in Intangibles changed N/A year-over-year to $63.9 million; the TTM figure through Mar 2026 stood at $63.9 million (changed N/A YoY), while the FY2009 annual figure was $2.3 million, changed N/A from the prior year.
- Change in Intangibles for Q1 2026 stood at $63.9 million.
- The five-year high for Change in Intangibles was $63.9 million in Q1 2026, with the low at $63.9 million in Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.77 Bn | 130.92 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.51 Bn | 77.52 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.20 Bn | 53.06 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | - |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.40 Bn | 27.56 Bn | - | - |
| 9 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn | - |
| 10 | Agenus | 343.02 Mn | 343.02 Mn | 34.52 Mn | - |